Osteoporosis is a condition that effects bones and cause them to turn weak and brittle which raises the risk of fractures. This condition affects both males and females of all ages though it is normally linked with postmenopausal women. The female hormone oestrogen plays an important role in bone health but after menopause the production oestrogen falls.
In a new study researchers have found that a hormone which controls your inner body clock can help in treating osteoporosis. Pill form of hormone known as melatonin is being provided to women over the age of forty-five in a clinical trail to test its benefits.
There is an even series of new development and deletion of old bones in healthy young bones called bone turnover. As you age more bones are detached that causes loss of bone density and other changes which jointly makes bones more brittle. Conventional treatment include, use of bisphosphonates drug, strontium ranelate and vitamin D.
HRT is also used that increases the level of oestrogen in the body but its long term use over number of years could increase the risk of stroke. In new study researchers from University of Pittsburgh in the US are observing melatonin as a substitute treatment. Melatonin is a hormone which is discharged by the pineal gland in the brain.
Hormone melatonin is made in the hours of darkness and regulates the internal clock of the body. It also regulates the release and timing of oestreogen hormone in females. Melatonin also has an influential antioxidant consequence, therefore it can help to avert the inflammation and injury which escorts to bone breakdown.
Researchers from University of Pittsburgh hope that women taking melatonin would show overall improvement in bone health. Moreover, they would have better control over their menopausal symptoms, better quality of life and less disturbances in sleep. The finding might prove efficient and an economical way to help millions of people who suffer from osteoporosis.